Are you Dr. Rubinsak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
901 Tamiami Trl S
Venice, FL 34285Phone+1 941-484-3531Fax+1 941-486-1701- Is this information wrong?
Summary
- Dr. James Rubinsak, MD is an oncologist in Venice, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with Venice Regional Bayfront Health.
Education & Training
Keesler Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Mississippi School of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 1985 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Sarasota Magazine: Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Start of enrollment: 2009 Feb 01
Publications & Presentations
PubMed
- 8 citationsPhase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung CancerDavid R. Spigel, F. Anthony Greco, Dana S. Thompson, Charles D. Webb, James R. Rubinsak, Roger Inhorn, James A. Reeves, Elizabeth R. Vazquez, Cassie M. Lane, Howard A....> ;Clinical Lung Cancer. 2010 May 1
- Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC).Rubinsak JR, Spigel DR, Hainsworth JD, Webb C, Inhorn RC, Infante JR, Yardley DA, Burris HA, Vazquez ER, Greco FA> ;J. Clin. Oncol.. 2008-05-20
- 26 citationsSingle-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.David R. Spigel, John D. Hainsworth, Emily R. Burkett, Howard A. Burris, Denise A. Yardley, Melodie Thomas, Suzanne F. Jones, Natalie R. Dickson, Daniel C. Scullin, Ja...> ;Clinical Lung Cancer. 2005 Sep 1
- Join now to see all
Hospital Affiliations
- Venice Regional Bayfront HealthVenice, Florida
